AZ’s Airsupra (albuterol and budesonide ... treatment used to reduce exacerbations in people living with chronic obstructive pulmonary disease (COPD). Sales of Breztri were $677 million ...

In the MANDALA trial, Airsupra was found to significant reduce the risk of severe exacerbations compared to albuterol in patients ... pulmonary disease (COPD) in the US, with the first patients ...

researchers compared heliox versus oxygen for delivery of continuous nebulized albuterol in 30 children aged 2 to 18 years with moderate to severe asthma exacerbations. The study was partially ...

The following is a summary of “Treating eosinophilic exacerbations of asthma and COPD with benralizumab (ABRA): a ...

In asthma, lower end-tidal carbon dioxide may predict acute exacerbation outcomes, although other measures may be better severity indicators.

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

Episodes of COPD exacerbation are also common in severe COPD. This is the most severe stage of COPD. Your FEV1 is less than 30% of normal predicted values or less than 50% with chronic respiratory ...

Objective: To investigate the efficacy and tolerability of high-dose N-acetylcysteine (NAC) in the treatment of patients with exacerbations of chronic obstructive pulmonary disease (COPD).

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

As Los Angeles continues to grapple with the widespread devastation of the recent wildfires, the impact extends far beyond incinerated buildings and scorched landscapes. The plumes of ...